In 2005, when the Labour Party decided to implement the National Identity Project (NIP) in the UK, it drew severe criticism from many quarters, including the Tories, who later scrapped the NIP after coming to power. A report by the London School of Economics (LSE), which stated the project is “unsafe in law” and should be regarded as a “potential danger to public interest”, was instrumental in buttressing the arguments...

-The Telegraph   The New York Times has reported that Wal-Mart, the US-based retail giant, hushed up an internal investigation sometime after the company was told of a bribery campaign to obtain licences and facilitate rapid expansion in Mexico. Some of the alleged instances of bribery are certain to ring a bell in India where it is not too difficult to bend rules for a price. The New York Times said its “examination...

There is evidence to show that growth is slowly becoming inclusive. But for the quality of life to improve, incomes must be complemented by infrastructure. For close to at least five years now inclusive growth has had a central place in the official discourse on the economy. The UPA II has itself worn its self-proclaimed success in delivering an inclusive growth as a badge of its effectiveness, not to mention its...

Arundhati has got it all wrong—the facts speak out against her romantic notions of the tribals’ fight Nirad C. Chaudhary wrote in The Continent of Circe that India’s tribals were mainly found in hill forests. This was because, he reasoned, they had been chased there by the invading Aryans, who displaced them from their river plains. In an essay published in this magazine (Capitalism: A Ghost Story, March 26), Arundhati Roy...

The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...